Marotta Asset Management Genmab A/S Transaction History

Marotta Asset Management

$497 Million
Q2 2025

A detailed history of Marotta Asset Management transactions in Genmab A/S stock. As of the latest transaction made, Marotta Asset Management holds 12,084 shares of GMAB stock, worth $245,305. This represents 0.05% of its overall portfolio holdings.

Number of Shares

12,084

Previous 13,532 10.7%

Holding current value

$245,305

Previous $264,000 5.68%

% of portfolio

0.05%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 02, 2025	SELL	$17.98 - $23.09 $26,035 - $33,434	-1,448 Reduced 10.7%	12,084 $249,000
Q1 2025 Apr 02, 2025	BUY	$18.69 - $24.14 $13,811 - $17,839	739 Added 5.78%	13,532 $264,000
Q4 2024 Jan 10, 2025	SELL	$20.02 - $24.15 $14,794 - $17,846	-739 Reduced 5.46%	12,793 $266,000
Q3 2024 Oct 03, 2024	SELL	$23.84 - $28.48 $2,646 - $3,161	-111 Reduced 0.81%	13,532 $329,000
Q2 2024 Jul 17, 2024	SELL	$25.13 - $30.27 $35,156 - $42,347	-1,399 Reduced 9.3%	13,643 $342,000
Q1 2024 Apr 02, 2024	SELL	$26.43 - $32.77 $13,822 - $17,138	-523 Reduced 3.36%	15,042 $449,000
Q4 2023 Jan 03, 2024	SELL	$27.94 - $35.44 $24,754 - $31,399	-886 Reduced 5.39%	15,565 $495,000
Q3 2023 Oct 11, 2023	SELL	$35.27 - $42.24 $19,857 - $23,781	-563 Reduced 3.31%	16,451 $580,000
Q2 2023 Jul 05, 2023	SELL	$37.4 - $42.94 $7,667 - $8,802	-205 Reduced 1.19%	17,014 $646,000
Q4 2022 Jan 03, 2023	SELL	$33.8 - $47.06 $1,656 - $2,305	-49 Reduced 0.28%	17,219 $0
Q3 2022 Oct 11, 2022	BUY	$31.52 - $373.61 $2,300 - $27,273	73 Added 0.42%	17,268 $554,000
Q2 2022 Jul 21, 2022	SELL	$26.83 - $38.57 $1,663 - $2,391	-62 Reduced 0.36%	17,195 $558,000
Q1 2022 Apr 08, 2022	SELL	$30.95 - $39.68 $4,890 - $6,269	-158 Reduced 0.91%	17,257 $624,000
Q4 2021 Jan 13, 2022	BUY	$35.87 - $47.12 $12,877 - $16,916	359 Added 2.1%	17,415 $688,000
Q3 2021 Oct 21, 2021	SELL	$41.55 - $48.72 $8,642 - $10,133	-208 Reduced 1.2%	17,056 $745,000
Q2 2021 Jul 09, 2021	BUY	$32.88 - $44.57 $63,261 - $85,752	1,924 Added 12.54%	17,264 $704,000
Q1 2021 Apr 09, 2021	BUY	$30.92 - $44.4 $474,312 - $681,096	15,340 New	15,340 $503,000

Others Institutions Holding GMAB

# of Institutions

248

Shares Held

66.2M

Call Options Held

729K

Put Options Held

398K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.4B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marotta Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Marotta Asset Management with notifications on news.

Account

Marotta Asset Management Genmab A/S Transaction History